Cargando…
Identification of the HNSC88 Molecular Signature for Predicting Subtypes of Head and Neck Cancer
Head and neck squamous cell carcinoma (HNSC) exhibits genetic heterogeneity in etiologies, tumor sites, and biological processes, which significantly impact therapeutic strategies and prognosis. While the influence of human papillomavirus on clinical outcomes is established, the molecular subtypes d...
Autores principales: | Chuang, Yi-Hsuan, Lin, Chun-Yu, Lee, Jih-Chin, Lee, Chia-Hwa, Liu, Chia-Lin, Huang, Sing-Han, Lee, Jung-Yu, Lai, Wen-Sen, Yang, Jinn-Moon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487792/ https://www.ncbi.nlm.nih.gov/pubmed/37685875 http://dx.doi.org/10.3390/ijms241713068 |
Ejemplares similares
-
An Integrated Genomic Strategy to Identify CHRNB4 as a Diagnostic/Prognostic Biomarker for Targeted Therapy in Head and Neck Cancer
por: Chuang, Yi-Hsuan, et al.
Publicado: (2020) -
Identification of the Immune Cell Infiltration Landscape in Head and Neck Squamous Cell Carcinoma (HNSC) for the Exploration of Immunotherapy and Prognosis
por: Huang, Chunli, et al.
Publicado: (2022) -
Acircadian rhythm-related gene signature for predicting survival and drug response in HNSC
por: Zhang, Chuan, et al.
Publicado: (2022) -
CoMI: consensus mutual information for tissue-specific gene signatures
por: Huang, Sing-Han, et al.
Publicado: (2022) -
Prognostic impact of intra- and peritumoral immune cell subpopulations in head and neck squamous cell carcinomas – comprehensive analysis of the TCGA-HNSC cohort and immunohistochemical validation on 101 patients
por: Knebel, Moritz, et al.
Publicado: (2023)